Early sepsis recognition: a pilot study using a rapid high-multiplex host-response mRNA diagnostic test
TriVerity is a rapid whole-blood host-response test to reliably detect the presence or absence of bacterial and/or viral infections, as well as to assess illness severity in patients presenting to the ED. Its quick turnaround time aligns with the ED workflow, offering timely insights for clinical decision-making. Results from upcoming large-scale validation studies will provide more detailed results on the diagnostic and prognostic accuracy of the test.
Authors
- Jan C. ter Maaten (ORCID: https://orcid.org/0000-0002-0353-4011)
- Natalie N. Whitfield (ORCID: https://orcid.org/0000-0001-9937-9687)
- Oliver Liesenfeld (ORCID: https://orcid.org/0000-0002-4348-5509)
- Timothy E. Sweeney (ORCID: https://orcid.org/0000-0002-3596-1093)
- Hjalmar R. Bouma (ORCID: https://orcid.org/0000-0003-1032-321X)
- Mehtap Ünal (ORCID: https://orcid.org/0000-0002-0308-0291)
- Michèle Anna ter Voert
- Jingyi Lu (ORCID: https://orcid.org/0000-0002-0510-5034)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
Publication Details
- Journal
- Intensive Care Medicine Experimental
- Published
- 2025-02-21
- DOI
- https://doi.org/10.1186/s40635-025-00735-x
- Citations
- 7
- Primary Topic
- Bacterial Identification and Susceptibility Testing
- Type
- article
- Field-Weighted Citation Impact
- 9.23
Funders
- Health~Holland